SHAHINIAN ERIC purchased 5.4% of their position (88.90K shares) of PASITHEA THERAPEUTICS CORP. on the open market
Open‑market purchase worth $100.4K — a moderate purchase. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 9/6/2022ACC: 0001209191-22-048789
+88.90K
Net shares
Net buyer
$100.4K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
88.90K acquired
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+55.65K
Price / share
$1.13
Trade value
$62.63K
% of position
3.4%
9/1/2022
1.64M→1.69M
Common Stock
Indirect
Shares
+11.51K
Price / share
$1.14
Trade value
$13.11K
% of position
0.7%
9/2/2022
1.69M→1.70M
Common Stock
Indirect
Shares
+21.75K
Price / share
$1.13
Trade value
$24.63K
% of position
1.3%
9/6/2022
1.70M→1.72M
Total
Net shares
+88.90K
Net value
$100.37K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/1/2022 | P · Purchase | +55.65K | $1.13 | $62.63K | 3.4% | 1.64M | 1.69M |
| Common Stock Indirect | 9/2/2022 | P · Purchase | +11.51K | $1.14 | $13.11K | 0.7% | 1.69M | 1.70M |
| Common Stock Indirect | 9/6/2022 | P · Purchase | +21.75K | $1.13 | $24.63K | 1.3% | 1.70M | 1.72M |
| Total | +88.90K | $100.37K | ||||||
Derivative Transactions0
No derivative transactions reported